Bioinnovasp. z o.o. in liquidation
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2015-07-16
Share capital
400,000.00 PLN
Registered address
al. Wincentego Witosa 16, 20-315 Lublin, Poland
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Została podjęta uchwała dotycząca rozwiązania Spółki.
From the notes
| Profit allocation | No decision | |
| Merger or transformation | Yes |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 10 days late).
- 202503/07/2026
- 202407/07/2025
- 202309/07/2024
- 202222/06/2023
- 202125/07/2022
- 202024/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Voivodeship · Lubelskie15,232 / 15,986
Top 95%
Country · Poland469,079 / 495,976
Top 95%
Results vs industry
Revenue
This companyUSD 87.90MedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD -2.37kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 416.00MedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 2.35kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Maciej Jacek Manieckiage 64 – Liquidator
Supervisory board
Mariusz Kicia – Supervisory Board Member
Magdalena Miler-Wiśniewska – Supervisory Board Member
Zbigniew Pastuszak – Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Maciej Jacek Manieckiage 64 | 200 | $54,024.85 | 50% |
Uniwersytet Marii Curie-skłodowskiej | 200 | $54,024.85 | 50% |
Beneficial owners
No beneficial owners recorded for the company Bioinnova.
Bank accounts
Registered as a VAT taxpayer on 2016-08-02.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Sep 16, 2024 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | ||
| Microbe Plussp. z o.o. | $104,197.26 | microbe-plus.com | ||
| Vitagenumsp. z o.o. | $9,376.94 | vitagenum.pl | ||
| Meritrosp. z o.o. | $7,890.74 | meritro.com | ||
| Dairy Biotechnologiessp. z o.o. | $1,485.09 | milcu.eu | ||
| ImmunotronicsP.S.A. | $0.16 | immunotronics.net | ||
| Aiventrosp. z o.o. | $0.00 | aiventro.com | ||
| Walletmed Heartsp. z o.o. | – | walletmed.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-01-04 | Business resumed | |
| 2024-07-31 | Name change (Bioinnova → Bioinnova Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2024-07-09 | Liquidation opened | |
| 2024-01-03 | Business suspended | |
| 2024-01-02 | Business resumed |
FAQ
The main business activity of Bioinnova focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on July 16, 2015.
The headquarters is located at: Al. Wincentego Witosa 16, 20-315 Lublin.
The share capital of the company is PLN 400,000 (approx. $108,050).
The latest available financial statement covers the period from July 9, 2024 to December 31, 2024.
In 2024, the company's revenue reached $88.
No, in 2024 the company was not profitable, reporting a net loss of $2,362. For comparison, in 2023 the loss was $138, representing a multi-fold increase in the loss compared to 2023.
The largest operating cost category falls under other operating costs. This category amounted to $415 in 2024, representing 100% of all operating expenses.
Last updated: 2026-07-06